Oh, yes. But you can't do very much unless you have big
quantities of material. Because this is, cancer is a condition
that happens all over the world, and viral disease happens all over
the world. You've got to have an immense amount of material, so,
whichever manufacturers make it first will, or are in the lead and
make it best, will undoubtedly, ought to make a great fortune.

Q:

Well, I would think that the commercial stimulus of that would
do it, would --

Lasker:

Well, we hope it will. But you know, they're always busy
with other things, and they're always people without imagination,
and there's always, there are always road blocks to any human effort.
As you might have noticed.

Q:

Oh, yes. So, well, now, all of this going on in the world
in the field of experimentation with interferon, has the NIH
been budged to do anything?

Lasker:

Well, that I'll tell you about when we come into the
appropriations.

Q:

I see. All right.

Lasker:

Because they have been extremely slow about it.

Q:

Even reluctant?

Lasker:

And reluctant, and they purchased some in 1976 and didn't
give it out for over a year. After innumerable requests on the
part of Gutterman and me that they should deliver some, they
finally delivered it slightly over a year after they got it.
They are not known to have any more at the present moment, although